@dpavot:27872092 / 53-59
|
Our results validate Plk4 as a therapeutic target in cancer patients and reveal a new role for Plk4 in regulating Arp2/3-mediated actin cytoskeletal rearrangement.
|
projects
| Unselected / annnotation | Selected / annnotation | |
|
|
|
|